Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

FENNEC PHARMACEUTICALS INC. (FENC)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Revenues  3.01.50.0-5.00.00.00.00.0
            Revenue growth  -160.5%    -100.0%  
Cost of goods sold  -0.1-0.10.00.00.00.00.00.0
Gross profit  3.21.60.0-5.00.00.00.00.0
            Gross margin  104.9%106.4% 100.0%    
Selling, general and administrative   [+]7.86.87.13.92.13.72.93.1
Research and development  0.00.00.81.11.40.51.20.8
Other operating expenses     -5.0    
EBITDA   [+]        
Depreciation and amortization          
EBIT   [+]-4.7-5.3-7.9-5.0-3.5-4.2-4.2-3.9
            EBIT margin  -154.0%-354.4% 100.0%    
Interest income  0.10.10.00.00.00.00.00.0
Other income (expense), net   [+]-0.9-0.9-0.2-0.1-0.2-0.20.0-0.1
Pre-tax income  -5.4-6.1-8.1-5.1-3.7-4.4-4.2-4.0
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -5.4-6.1-8.1-5.1-3.7-4.4-4.2-4.0
            Net margin  -179.7%-407.0% 101.3%    
   
Basic EPS   [+]($0.21)($0.23)($0.31)($0.19)($0.14)($0.17)($0.16)($0.15)
Diluted EPS   [+]($0.21)($0.23)($0.31)($0.19)($0.14)($0.17)($0.16)($0.15)
   
Shares outstanding (basic)   [+]26.526.626.126.126.026.026.026.0
Shares outstanding (diluted)   [+]26.526.626.126.126.026.026.026.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy